Following FDA Green Light, Rivals Lining Up To Bring Generic Lovenox to Market

摘要

With the FDA granting approval to Sandoz and Momenta for the first generic version of Sanofi-Aventis' blood thinner Lovenox, a race to be the next to market is taking shape among companies including Teva Pharmaceutical, Watson Pharmaceuticals and Hospira.